{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Burbank",
      "state": "CA",
      "country": "United States",
      "classification": "Class I",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "90481",
      "recalling_firm": "Bryant Ranch Prepack, Inc.",
      "address_1": "1919 N Victory Pl",
      "address_2": "",
      "postal_code": "91504-3425",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Distributed to one wholesaler in AL for further distribution in the US.",
      "recall_number": "D-1188-2022",
      "product_description": "Morphine Sulfate extended-Release Tablets, USP; 60 mg, 100-count bottles, Rx only, manufactured by: Ohm Laboratories Inc., NJ; Relabeled by: Bryant Ranch Prepack, Inc, CA, NDC 63629-1089-01",
      "product_quantity": "",
      "reason_for_recall": "Labeling: Label Mix-up:  bottles labeled as Morphine Sulfate 60 mg Extended-Release tablets contain Morphine Sulfate 30 mg Extended-Release tablets and bottles labeled as Morphine Sulfate 30 mg Extended-Release tablets may contain Morphine Sulfate 60 mg Extended-Release tablets.",
      "recall_initiation_date": "20220617",
      "center_classification_date": "20220708",
      "termination_date": "20240402",
      "report_date": "20220720",
      "code_info": "Lot #: 179643, Exp. Date 08/31/2023.",
      "more_code_info": ""
    }
  ]
}